International Pharmaceutical Transparency Act of 2019

United States116th CongressHR-5381House of Representatives
Updated: Dec 11, 2019

Summary

International Pharmaceutical Transparency Act of 2019 This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.